Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma H Allott

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of the National Cancer Institute|September 2, 2017
Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer StudyMelissa A Troester, Xuezheng Sun, Emma H Allott, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 30, 2015
Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER ConsortiumEmma H Allott, Stephanie M Cohen, Joseph Geradts, et al.
Plos One|December 18, 2020
Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trialLauren Brady, Brian Hayes, Gráinne Sheill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate CancerEmma H Allott, Ericka M Ebot, Konrad H Stopsack, et al.
Cancers|September 28, 2021
Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21)Brian Hayes, Lauren Brady, Gráinne Sheill, et al.
Breast Cancer Research : BCR|February 8, 2018
Frequency of breast cancer subtypes among African American women in the AMBER consortiumEmma H Allott, Joseph Geradts, Stephanie M Cohen, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of the National Cancer Institute|September 2, 2017
Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer StudyMelissa A Troester, Xuezheng Sun, Emma H Allott, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 30, 2015
Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER ConsortiumEmma H Allott, Stephanie M Cohen, Joseph Geradts, et al.
Plos One|December 18, 2020
Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trialLauren Brady, Brian Hayes, Gráinne Sheill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate CancerEmma H Allott, Ericka M Ebot, Konrad H Stopsack, et al.
Cancers|September 28, 2021
Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21)Brian Hayes, Lauren Brady, Gráinne Sheill, et al.
Breast Cancer Research : BCR|February 8, 2018
Frequency of breast cancer subtypes among African American women in the AMBER consortiumEmma H Allott, Joseph Geradts, Stephanie M Cohen, et al.
Pageof 7